The Independent of London is reporting Donald Rumsfeld has made over $5 million in capital gains from selling shares in the biotechnology firm that discovered and developed Tamiflu. Tamiflu is one of the few drugs believed effective in treating avian bird flu. A new financial disclosure report shows Rumsfeld holds up to $25 million worth of shares in the company Gilead Sciences. The Pentagon has defended Rumsfeld’s holdings stating that he has no relationship with the Gilead Sciences beyond his investments in the company.